Navigation Links
Laser Surgery for Allergy

Allergy is a common affliction across the world especially when the pollen count is high in the atmosphere. //In the USA it affects more than 50 million people every year. In almost 38 million people, congestion and post nasal drip lead to more serious problems like chronic sinus infections. Newer treatments are now availble to combat such an allergy problem

Rajiv Pandit, M.D. a ENT and Head and Neck Surgeon at , of Methodist Dallas Medical Center, now uses a powerful laser to shrink nasal tissues called turbinates. He says: "This is the tip that is going to be placed in the nose. The idea is to vaporize some of this tissue as well as to cause a heat injury that, over several weeks, will reduce the size of the turbinate through the body's natural healing process."

The procedure is called "Laser sub-mucosal resection" and takes approx. about 15 minutes with immediate results.

"People generally feel more alert -- both at home and on the job. People usually sleep better, so they're more refreshed,"says Dr. Pandit.

Kathy McFarlane's problem was swollen tissues inside her nose that made it hard for her to breathe."I was severely congested. Had a lot of pressure, in my head, nose runny, eyes -- runny and itchy."

McFarlane who was treated by the laser technique is pleased and she says, "I have not had a single sinus infection since I had the laser turbinate surgery, so it's been a godsend and an answer to many prayers.

Minor side effects of sub-mucosal resection include nose bleeds and congestion. The procedure should be only be offered to patients who are not helped by standard anti allergy prescription drugs.


Page: 1

Related medicine news :

1. New Laser Techniques cure degeneration of the eye
2. Laser to help in root canal treatment
3. Laser technique assists beard problem
4. Laser dental treatment
5. Laser may stop macular degeneration
6. Macular Degeneration treatment with Laser
7. Lasers for Acne
8. Laser Therapy Found To Help People Quit Smoking
9. Zap the butt (cigarette) with Laser Therapy
10. Laser Used To Clear Blocked Arteries Preventing Amputation
11. Burning Fat, the Laser Way
Post Your Comments:

(Date:12/1/2015)... NY (PRWEB) , ... December 01, 2015 , ... ... non-traumatic limb amputations in the United States. Podiatrists are well aware that psychology-based ... adopt therapeutic behaviors) are often catastrophic contributors to diseases of the diabetic foot. ...
(Date:12/1/2015)... ... December 01, 2015 , ... For the ... is why Hollister Incorporated has launched the VaPro Plus Pocket™ touch free hydrophilic ... the VaPro touch free catheter portfolio,” said Michael Gresavage, Vice President North America. ...
(Date:12/1/2015)... ... December 01, 2015 , ... Next IT Healthcare, the leader ... in this year’s Fierce Innovation Awards: Healthcare Edition, an awards program from the ... finalist in the category of Digital Solutions for its innovative, industry-leading product, Alme ...
(Date:12/1/2015)... ... 2015 , ... TCS Healthcare Technologies (TCS), a leading provider ... is pleased to announce that VIP Care Services, a Caprock Health Group affiliate ... Complete Care™ Management to back their collaborative catastrophic case management initiatives. ACUITY Complete ...
(Date:12/1/2015)... GA (PRWEB) , ... December 01, 2015 , ... ... supports SACC-GA and SACC-USA through membership and leadership since 2008. Gary ... Chair for SACC-USA . Gary has spent a significant amount of time ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... BOSTON , December 1, 2015 Russia ... phase III clinical trials. 70% of new drugs registered in ... trials in Russia . --> Russia has ... trials. 70% of new drugs registered in Europe ... . --> Russia has always been ...
(Date:12/1/2015)... , Dec. 1, 2015 Relmada Therapeutics, Inc. ... treatment of chronic pain, announced today that the company will ... be held December 1-3 at the Luxe Sunset Boulevard Hotel ... Traversa , CEO of Relmada Therapeutics, will present on Thursday, ... Time). . Please register at least 10 ...
(Date:12/1/2015)...   MabVax Therapeutics Holdings, Inc . (OTCQB: MBVX), ... filed an Investigational New Drug Application (IND) with the ... lead fully human antibody product HuMab 5B1 as a ... initiate the Phase I clinical trial early in 2016. ... The planned Phase I trial will evaluate the safety, ...
Breaking Medicine Technology: